Literature DB >> 10968916

Apoptosis and the antiphospholipid syndrome.

J Rauch1, R Subang, P D'Agnillo, J S Koh, J S Levine.   

Abstract

The target of many antiphospholipid autoantibodies (APA) has been shown to be a complex between anionic phospholipid (PL) and the plasma protein beta 2-glycoprotein I (beta 2-GPI), but the identity of the natural target(s) and/or immunogen for APA in vivo remains undetermined. The anionic PL of cell membranes represent important potential targets and immunogenes for APA. Although anionic PL are normally absent from the extracellular surface of cell membranes, they redistribute from the inner to the outer leaflet during apoptosis. We and others have shown that beta 2-GPI binds selectively to the surface of apoptotic, but not viable, cells, and that the binding of beta 2-GPI to the surface of apoptotic cells generates an epitope recognized by APA from patients with both primary antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). In this review, we discuss recent findings, which suggest not only that apoptotic cell-bound beta 2-GPI is injected by non-intravenous routes. We also review briefly the potential role of oxidation in generating epitopes responsible for the recognition and induction of APA. Taken together, we believe that the available evidence supports a role for apoptotic cells as far as targets of APA and possible players in the induction of APA. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968916     DOI: 10.1006/jaut.2000.0396

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

Review 1.  Do antiphospholipid antibodies develop for a purpose?

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 3.  Apoptosis and autoimmunity.

Authors:  Jeannine S Navratil; Chau-Ching Liu; Joseph M Ahearn
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome.

Authors:  Shina Pashova; Lubomir Balabanski; Gabriel Elmadjian; Alexey Savov; Elena Stoyanova; Velizar Shivarov; Peter Petrov; Anastas Pashov
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

Review 5.  Antiphospholipid syndrome.

Authors:  Sanjay C Keswani; Naresh Chauhan
Journal:  J R Soc Med       Date:  2002-07       Impact factor: 18.000

6.  Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation-Mechanisms analyzed using hydrogen/deuterium exchange.

Authors:  Kuo-Tung Tang; Ting-Yuan Wu; Hsin-Hua Chen; Chi-Chien Lin; Yuan-Hao Howard Hsu
Journal:  Protein Sci       Date:  2021-03-15       Impact factor: 6.725

Review 7.  Antiphospholipid syndrome infectious origin.

Authors:  M Blank; R A Asherson; R Cervera; Y Shoenfeld
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.